What service do you need? Contact Request

NCT06599684

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

← Clinical trials hub

Registry fields

Overall status: COMPLETED
Conditions: Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy, Center-involved Diabetic Macular Edema, Center-involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Study type: INTERVENTIONAL
Phase: PHASE2
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: INV-102
Lead sponsor: Invirsa, Inc. (INDUSTRY)

Cached at: 2026-10-03 09:00:04

View on ClinicalTrials.gov

Brief summary

Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME (NCIDME) associated with NPDR \[Part 1\] and during an 8-week dosing period in subjects with center-involved DME (CIDME) associated with NPDR \[Part 2\].

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report

Contact Support